Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ENDRA Life Sciences Inc. (NDRA) vs Psychemedics Corporation (PMD)

ENDRA Life Sciences Inc. and Psychemedics Corporation are both Diagnostics & Research companies. Psychemedics Corporation is the larger, with a market value of $15.7M against $8.9M — 1.8× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −9.45%) and the lower return on invested capital (−539.9% vs −31.4%). Across the 16 metrics below, Psychemedics Corporation leads on 10 and ENDRA Life Sciences Inc. on 6.

Valuation

Metric NDRA PMD Diagnostics & Research median
P/E n/m n/m 33.95
P/S 22.35 0.80 4.87
P/B 1.27 3.05 3.12
Price to free cash flow n/m 19.46 34.02
EV/EBITDA n/m 77.29 25.20
EV/Sales 7.61 0.74 5.66
Earnings yield (104.64%) (11.99%) (1.75%)
Free cash flow yield (98.06%) 5.14% (0.13%)

Profitability

Metric NDRA PMD Diagnostics & Research median
Gross margin 0.00% 36.07% 50.89%
Operating margin 0.00% (9.62%) (8.57%)
Net margin 0.00% (9.45%) (6.37%)
Free cash flow margin 0.00% 4.02% 0.00%
Return on equity (152.04%) (31.54%) (2.92%)
Return on assets (110.08%) (18.03%) (6.71%)
Return on invested capital (539.89%) (31.42%) 0.00%

Growth

Metric NDRA PMD Diagnostics & Research median
Revenue growth (TTM) — (10.92%) 7.69%
EPS growth (last fiscal year) 84.32% 55.56% —
Revenue growth, 5-year CAGR — (12.18%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA PMD Diagnostics & Research median
Debt to equity 0.00 0.01 0.11
Current ratio 7.10 1.82 2.02
Net debt to EBITDA 0.14 (7.26) 0.78

Dividend

Metric NDRA PMD Diagnostics & Research median
Dividend yield — 4.79% 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric NDRA PMD Diagnostics & Research median
Market cap 8.89m 15.70m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack